Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Transplantation · Clin Transplant · 2026-11-01
Guideline
Pereira Are You Ready to Tackle the Troll? New Guidelines for the Management of Posttransplant Cytomegalovirus InfectionTransplantation · Clin Transplant · 2026-10-01
Secondary analysisn = 158
Murbraech et al. Development in Left Ventricular Mass After Early and Late Conversion From Calcineurin Inhibitors to Everolimus in Heart Transplant Recipients-Results From Two Randomized Controlled TrialsTransplantation · Transpl Int · 2026-09-23
RCTn = 60
Snanoudj et al. Bortezomib in combination with standard-of-care for late active antibody-mediated rejection with de novo donor-specific antibodies after kidney transplantation: a multicenter randomized trialTransplantation · Transpl Int · 2026-09-18
Guideline
Bos et al. European society for organ transplantation clinical practice guideline on prevention and treatment of chronic lung allograft dysfunctionTransplantation · Am J Transplant · 2026-08-22
Guideline
Kumar et al. Vaccination and safe living strategies for solid organ transplant candidates and recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of PracticeTransplantation · Bone Marrow Transplant · 2026-08-21
RCTn = 79
Walker et al. A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants - a study from the Cell Therapy Transplant Canada/ Australasian Leukemia Lymphoma Group ConsortiumTransplantation · Transplantation · 2026-06-23
Meta-analysisn = 41 studies
Lattimore et al. Impact of Intrapatient Immunosuppression Variability in Renal Transplantation Outcomes: A Systematic Review and Meta-analysisTransplantation · Transplantation · 2026-06-18
Guideline
Grünewald et al. Evidence- and Consensus-based European Guideline for Immunosuppressive Therapy After Pediatric Kidney TransplantationTransplantation · J Heart Lung Transplant · 2026-06-11
Guideline
Calabrese et al. International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP) definitionTransplantation · Am J Transplant · 2026-05-27
RCTn = 148
Shemesh et al. A remote intervention to improve medication nonadherence guided by a marker of risk derived from the electronic health records of adolescent transplant recipientsTransplantation · Am J Transplant · 2026-05-22
RCTn = 31
Boutin et al. A phase 2 multicenter, prospective, randomized, double-blind study to assess the clinical and antiviral efficacy and safety of nitazoxanide for the treatment of norovirus in hematopoietic stem cell and solid organ transplant recipientsTransplantation · Transplant Cell Ther · 2026-05-20
Guideline
DeFilipp et al. Clinical Management of Acute Graft-Versus-Host Disease: An Evidence-Based Review from the ASTCT Committee on Practice GuidelinesTransplantation · Transplantation · 2026-05-04
RCTn = 60
Tremblay et al. Safety, Pharmacokinetics, and Pharmacodynamics of Fixed-dose, Subcutaneous, and Intravenous Administration of VEL-101, an Anti-CD28 PEGylated Monoclonal Antibody Fragment, in Healthy Participants: A Randomized, Double-blind, Placebo-controlled, Dose Escalation, Phase 1 StudyTransplantation · Transplant Cell Ther · 2026-04-30
RCTn = 128
Moiseev et al. A randomized, multicenter phase II trial to compare prophylaxis of graft versus host disease with tacrolimus and mycophenolate mofetil versus ruxolitinib after post-transplant cyclophosphamideTransplantation · J Heart Lung Transplant · 2026-04-02
RCTn = 59
Chambers et al. The ASSIST CLAD study: A phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunctionTransplantation · Clin Transplant · 2026-04-01
Meta-analysisn = 5,428
Yamada et al. Subclinical and Borderline Rejection are Associated With Death-Censored Graft Loss After Kidney Transplantation: A Systematic Review and Meta-AnalysisTransplantation · Clin Transplant · 2026-02-01
Meta-analysisn = 148
Feng et al. Impact of C1-Inhibitor on Renal Function and Safety Outcomes in Kidney Transplant Recipients: A Meta-Analysis of Randomized Controlled TrialsTransplantation · Clin Transplant · 2026-01-01
Meta-analysisn = 477
Gadelmawla et al. Organ Responses, Survival, and Safety of Belumosudil in Chronic Graft-Versus-Host Disease: A Systematic Review and Meta-AnalysisTransplantation · Am J Transplant · 2025-11-26
RCTn = 15
Chandran et al. Pharmacokinetics, lineage identity, and trafficking of ex vivo expanded polyclonal regulatory T cells in a prospective randomized clinical trial of kidney transplant recipients with allograft inflammation